| Financial Year |
March 31 2023 |
| Monetary Funds |
259,703,978.95 |
| Held-for-trading Financial Assets |
8,500,000.00 |
| Notes Receivable |
13,018,095.74 |
| Accounts Receivable |
318,897,929.34 |
| Advances to Suppliers |
16,534,235.50 |
| Other Receivables |
10,407,239.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
255,178,401.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
513,897.63 |
| Total Current Assets |
885,005,300.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
72,463,400.27 |
| Fixed Assetes |
574,816,322.22 |
| Under-construction Projects |
20,350,566.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,628,204.61 |
| R&D expenses |
6,893,055.57 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
326,757.96 |
| Deferred Income Tax Assets |
79,648,084.95 |
| Other Non-Current Assets |
93,435,094.63 |
| Sub-Total of Non-Current Assets |
912,462,604.64 |
| Total Assets |
1,797,467,904.68 |
| Short-Term Loans |
312,390,041.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,789,941.38 |
| Accounts Payable |
144,135,578.75 |
| Accounts Received In Advance |
871,500.51 |
| Employee Compensation Payable |
52,755,946.15 |
| Taxes Payable |
39,498,423.43 |
| Interest Payable |
-- |
| Dividend Payable |
1,713,981.80 |
| Other payables |
33,284,458.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,853,968.11 |
| Other Current Liabilities |
16,510,570.07 |
| Sub-Total of Current Liabilities |
652,662,826.11 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,371,354.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
36,389,590.69 |
| Total Liabilities |
689,052,416.80 |
| Paid-In Capital(Or Share Stock) |
358,000,000.00 |
| Capital Surplus |
313,001,594.20 |
| Surplus Reserve |
69,184,667.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
301,660,906.52 |
| Minority Stockholder's Interest |
66,177,909.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,042,237,578.02 |
| Owner's Equity（Stockholder's Equity） |
1,108,415,487.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,797,467,904.68 |
